Cita APA

Harrington, K. J., Burtness, B., Greil, R., Soulières, D., Tahara, M., Castro, G. d., . . . Rischin, D. (2022). Pembrolizumab with or without chemotherapy in recurrent or metastatic head and neck squamous cell carcinoma: Updated results of the phase III KEYNOTE-048 study.

Citación estilo Chicago

Harrington, Kevin J., et al. Pembrolizumab With or Without Chemotherapy in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: Updated Results of the Phase III KEYNOTE-048 Study. 2022.

Cita MLA

Harrington, Kevin J., et al. Pembrolizumab With or Without Chemotherapy in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: Updated Results of the Phase III KEYNOTE-048 Study. 2022.